Company’s Capital Bolstered as Shares List on NSE Emerge
MUMBAI (India CSR) – Influx Healthtech Limited, a key player in the healthcare products sector, has significantly transformed its shareholding structure following a successful Initial Public Offering (IPO) and a substantial bonus share issuance. These strategic moves have seen the company’s equity shares commence trading on the NSE Emerge platform, marking a new chapter in its financial journey. The company formally communicated these details, along with its Annual Report for Financial Year 2024-2025, to the National Stock Exchange of India Limited on August 14, 2025.
The restructuring aims to support the company’s expansion plans and operational enhancements, which were a stated objective of its public issue.
Evolution of Share Capital
Influx Healthtech Limited has witnessed a notable increase in both its authorized and paid-up share capital. As of March 31, 2025, the company’s Authorized Share Capital stands at INR 25,00,00,000, divided into 2,50,00,000 Equity Shares of INR 10/- each. This represents a significant increase from the previous authorized capital of INR 10,00,00,000, which was approved via a Shareholder’s resolution on April 4, 2024.
The Paid-up Share Capital as of March 31, 2025, is INR 18,15,00,000, comprising 1,81,50,000 Equity Shares of INR 10/- each. This increase in paid-up capital was primarily due to the issuance of bonus shares in the ratio of 725:1 (seven hundred and twenty-five new equity shares of INR 10/- each for every one existing equity share) through an allotment resolution dated July 31, 2024.
Here’s a breakdown of the company’s share capital:
| Capital Type | Amount (INR) as of Mar 31, 2025 | Number of Equity Shares (INR 10/- each) | Previous Amount (INR) | Date of Change/Resolution |
| Authorized Share Capital | 25,00,00,000 | 2,50,00,000 | 10,00,00,000 | April 04, 2024 |
| Paid-up Share Capital | 18,15,00,000 | 1,81,50,000 | – | July 31, 2024 |
Successful Initial Public Offering (IPO)
The company conducted its Initial Public Offering (IPO) between June 18, 2025, and June 20, 2025. The shares were allotted on June 23, 2025, and began trading on the NSE Emerge (SME) Platform from June 25, 2025.
The IPO involved a total of 6,100,800 Equity Shares, each with a face value of ₹10/-. The shares were offered at a price of Rs. 96/- per share, which included a premium of Rs. 86/- per share. Through this offering, Influx Healthtech Limited successfully raised Rs. 4800.38 Lakhs. The IPO consisted of 5,000,400 Fresh Equity Shares and an Offer for Sale (OFS) of 1,100,400 Equity Shares by Munir Abdul Ganee Chandniwala, the selling shareholder.
Below are the key details of the IPO:
| IPO Component | Details | Source |
| Total Equity Shares | 6,100,800 | |
| Fresh Issue | 5,000,400 Equity Shares | |
| Offer for Sale | 1,100,400 Equity Shares | |
| Selling Shareholder | Mr. Munir Abdul Ganee Chandniwala | |
| Face Value | ₹ 10/- per share | |
| Offer Price | ₹ 96/- per share (including a premium of ₹ 86/-) | |
| Total Funds Raised | ₹ 4800.38 Lakhs | |
| Subscription Period | June 18, 2025 – June 20, 2025 | |
| Allotment Date | June 23, 2025 | |
| Listing Date | June 25, 2025 | |
| Listing Platform | NSE Emerge (SME Platform) |
Notable Shareholdings and Related Information
The company’s records indicate specific shareholdings for directors and key employees. As of August 8, 2025, Abdul Ganee Abdul Rasul Chandniwala, a Non-Executive Director, held 726 shares in the company. He is also the father of Mr. Munir Abdul Ganee Chandniwala, Chairman and Managing Director, and father-in-law of Mrs. Shirin Munir Ahmed Chandniwala, Whole-time Director.
Furthermore, the annual report provides insights into the shareholding of certain employees during the financial year 2024-25, specifically those among the top 10 earners in terms of remuneration:
| Individual | Role | Shareholding (FY 2024-25) | Source |
| Moiz Palgharwala | Chief Operating Officer | 0.003136% | |
| Nafisa Chandniwala | Accounts – Employee | 0.003136% |
Shareholders holding shares as of August 8, 2025, were eligible to receive the Notice along with the Annual Report. For e-voting purposes, the cut-off date to determine voting rights was Wednesday, September 3, 2025. The e-voting period commenced on September 6, 2025, at 9:00 A.M. IST and concluded on September 8, 2025, at 5:00 P.M. IST.
These developments underscore Influx Healthtech Limited’s commitment to strengthening its capital base and enhancing its public presence as it moves forward with its business objectives.
(India CSR)
